Burden of Disease Matters When It Comes to Systemic Therapy for Prostate Cancer

被引：2
作者：
Harrison, Michael R. [1 ]
Armstrong, Andrew J. [1 ,2 ]
机构：
[1] Duke Univ, Med Ctr, Duke Canc Inst, Dept Med, Durham, NC USA
[2] Duke Univ, Med Ctr, Duke Canc Inst, Dept Surg, Durham, NC USA
来源：
EUROPEAN UROLOGY | 2015年 / 67卷 / 03期
关键词：
PROGNOSTIC MODEL; SURVIVAL; CASTRATION; MEN; CHEMOTHERAPY; NOMOGRAM;
D O I：
10.1016/j.eururo.2014.02.032
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：448 / 450
页数：3
相关论文
共 50 条
  • [1] Systemic therapy of prostate cancer in elderly patients
    von Amsberg, Gunhild
    Busenbender, Tobias
    Tilki, Derya
    Bokemeyer, Carsten
    ONKOLOGIE, 2024, 30 (02): : 119 - 128
  • [2] The Changing Landscape of Systemic Therapy in the Treatment of Synchronous Metastatic Hormone-sensitive Prostate Cancer
    Lambert, Edward
    Lumen, Nicolaas
    Fonteyne, Valerie
    De Maeseneer, Daan
    Verbeke, Sofie
    Villeirs, Geert
    De Man, Kathia
    Van Praet, Charles
    CLINICAL GENITOURINARY CANCER, 2023, 21 (03) : e1 - e8
  • [3] Oligometastatic prostate cancer: definition and the role of local and systemic therapy: a narrative review
    Mahjoub, Samy
    Heidenreich, Axel
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (07) : 3167 - 3175
  • [4] Systemic therapy in metastatic prostate cancer
    Auclerc, G
    ANNALES D UROLOGIE, 2000, 34 (01) : 39 - 48
  • [5] Management of Prostate Cancer with Systemic Therapy: A Prostate Cancer Unit Perspective
    Campodonico, Fabio
    Ennas, Marco
    Zanardi, Silvia
    Zigoura, Ekaterini
    Piccardo, Arnoldo
    Foppiani, Luca
    Schiavone, Concetta
    Squillace, Lino
    Benelli, Andrea
    De Censi, Andrea
    Grillo-Ruggieri, Filippo
    Introini, Carlo
    CURRENT CANCER DRUG TARGETS, 2021, 21 (02) : 107 - 116
  • [6] Update on systemic therapy for advance prostate cancer
    Carthon, Bradley
    Rossi, Peter J.
    CURRENT PROBLEMS IN CANCER, 2015, 39 (01) : 52 - 62
  • [7] Treatment in hormone-sensitive metastatic prostate cancer: factors to consider when personalizing therapy
    Aragon-Ching, Jeanny B.
    Dreicer, Robert
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (06) : 483 - 490
  • [8] Navigating systemic therapy for metastatic castration-naive prostate cancer
    Kwan, E. M.
    Thangasamy, I. A.
    Teh, J.
    Alghazo, O.
    Sathianathen, N. J.
    Lawrentschuk, N.
    Azad, A. A.
    WORLD JOURNAL OF UROLOGY, 2021, 39 (02) : 339 - 348
  • [9] Is there an indication for adjuvant or neoadjuvant systemic therapy in prostate cancer?
    Boergermann, C.
    Miller, K.
    vom Dorp, F.
    Jaeger, T.
    Ruebben, H.
    UROLOGE, 2007, 46 (10): : 1385 - +
  • [10] Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate Cancer
    Kim, Albert H.
    Konety, Badrinath
    Chen, Zhengyi
    Schumacher, Fredrick
    Kutikov, Alexander
    Smaldone, Marc
    Abouassaly, Robert
    Khanna, Abhinav
    Kim, Simon P.
    UROLOGY, 2018, 120 : 173 - 179
12345